Related Experiment Video
Updated: Oct 3, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
The activity of transcription factor IIIC1 is impaired during differentiation of F9 cells
Wolfgang Meissner1, Renate Thomae, Klaus H Seifart
1Institut für Molekularbiologie und Tumorforschung, Philipps Universität Marburg, Lahnstrasse 3, D-35037 Marburg, Germany. meissner@imt.uni-marburg.de
Abstract:
Differentiation in vitro of mouse F9 embryonal carcinoma (EC) cells to the parietal endoderm (PE) mimics processes of development of the early mouse embryo. This differentiation is accompanied by a dramatic down-regulation of all genes transcribed by RNA polymerase III (pol III). Complementation of extracts from cells, differentiated for various time periods with purified pol III transcription factors show for the first time that TFIIIC1 can substantially restore this impaired transcription, particularly in the early stages of differentiation. At later stages (day 7) the TBP (TATA-binding protein )-TAF complex, TFIIIBbeta, may also become limiting, which can contribute to but cannot account for the reduced transcription of type 2 promoters in PE cells. Because TFIIIBbeta is not required for the expression of type 3 promoters, other components must necessarily be involved, and our results show that U6 transcription can significantly be reactivated by TFIIIC1. By employing a variant type 3 promoter construct, which essentially requires a mutant form of TBP (TBP-DR2), we show that TBP is not limiting in PE extracts. The partial purification of pol III transcription factors from PE and EC cells revealed that TFIIIC2 activity could be purified from both cell types, whereas TFIIIC1 activity was dramatically reduced in extracts from PE cells.
Insights
Mouse embryonal carcinoma cell differentiation involves reduced RNA polymerase III transcription. TFIIIC1 factor can restore this impaired transcription, especially early on, while TBP-TAF complex may also be limiting later.
Area of Science:
- Developmental Biology
- Molecular Biology
- Gene Regulation
Background:
- Differentiation of mouse F9 embryonal carcinoma (EC) cells to parietal endoderm (PE) models early mouse embryo development.
- This differentiation process is marked by a significant decrease in RNA polymerase III (pol III) transcription.
Purpose of the Study:
- To investigate the specific pol III transcription factors that become limiting during EC cell differentiation.
- To elucidate the role of transcription factor IIIC subunit 1 (TFIIIC1) and TATA-binding protein (TBP)-TAF complex in the down-regulation of pol III transcription.
Main Methods:
- In vitro differentiation of mouse F9 EC cells.
- Complementation assays using cell extracts and purified pol III transcription factors.
- Partial purification of pol III transcription factors from differentiated and undifferentiated cells.
- Analysis of type 2 and type 3 promoter transcription.
Main Results:
- TFIIIC1 significantly restores impaired pol III transcription in early differentiation stages.
- TBP-TAF complex (TFIIIBbeta) may become limiting at later stages but does not fully explain reduced transcription of type 2 promoters.
- TFIIIC1 can reactivate U6 transcription (type 3 promoter), indicating TBP is not limiting.
- TFIIIC1 activity is dramatically reduced in PE cell extracts, while TFIIIC2 activity is present in both EC and PE cells.
Conclusions:
- TFIIIC1 is a key limiting factor for pol III transcription during early mouse EC cell differentiation.
- Reduced TFIIIC1 activity contributes significantly to the overall down-regulation of pol III-dependent genes in parietal endoderm cells.
- Other factors, in addition to TFIIIBbeta, are involved in the regulation of type 3 promoter transcription during differentiation.
Related Concept Videos
General Transcription Factors
Transcription Factors
Master Transcription Regulators
RNA Polymerase II Accessory Proteins
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
